Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
5Y CAGR+40.0%
Studio
Year-over-Year Change

Interest expense on outstanding debt

5Y CAGR
+40.0%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.78M+138.5%
2024$2.00M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$889000.00-
2019$0.00-
2018$0.00-
2017$0.00-